Dr. Anthony Thomas Corcoran, MD

Dr. Corcoran practices at NYU Langone Hospitals - Long Island in Mineola, New York.

Dr. Corcoran's NPI, 1891959292, was assigned on July 15, 2008. Dr. Corcoran graduated from SUNY Downstate Health Sciences University in 2005. Dr. Corcoran's Pennsylvania license number on file is MD433552.

Dr. Corcoran's primary practice is NYU Langone Hospitals - Long Island, at 259 1st St, Mineola, NY 11501 in Nassau County. The practice phone is (516) 576-1820.

Dr. Corcoran's primary practice is NYU Langone Hospitals - Long Island in Mineola, New York. Dr. Corcoran is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Corcoran to 2 more hospitals, 2 group practices and clinics, 2 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corcoran practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Corcoran's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Corcoran is board certified in urology by the American Board of Urology. Dmand AI has Dr. Corcoran's licenses on file in 2 states: Pennsylvania and New York.

Dmand AI lists bladder removal, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, prostate cancer, prostate inflammation or infection and prostate surgery among the conditions Dr. Corcoran treats.

CMS data shows 2,451 Medicare services from Dr. Corcoran across 28 procedure codes in 2024, for 792 Medicare patients. Medicare paid $302,869 for them.

CMS counts 792 Medicare patients who saw Dr. Corcoran in 2024. The largest group is 65 to 74, with 376 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Corcoran's median patient age at 72, with 16% women.

In 2024, Dr. Corcoran wrote 547 Medicare Part D claims for 236 patients. 87% of them were for generic drugs. CMS names the drug for 434 of them, across 11 drugs with 11 or more claims each, at $27,534 in total drug cost. In 2023, CMS named 559 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Corcoran for performance year 2024, reported as part of a group. Dr. Corcoran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Corcoran as offering telehealth. CMS counts 41 procedures of prostate resection by Dr. Corcoran, more than 95% of the clinicians it reports for that procedure.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 58 papers to Dr. Corcoran, published from 2008 to 2024. 2014 was the busiest year, with 10. The most frequent topics are Prostatic Neoplasms, Kidney Neoplasms and Carcinoma, Renal Cell. Dr. Corcoran has published most often in J Urol. Dr. Corcoran's most frequent co-authors are David Yen Tang Chen, MD, Reza Mehrazin, MD and Jeffrey Todd Schiff, MD.

Dmand AI links Dr. Corcoran to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 49 general payments to Dr. Corcoran from 12 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 40% of the total. Intuitive Surgical, Inc. paid the most, $7,011.

Dmand AI lists 1 award for Dr. Corcoran, most recently Alpha Omega Alpha in 2005. Dr. Corcoran serves on Executive Cancer Committee and OR Committee.

Dr. Corcoran graduated from SUNY Downstate Health Sciences University in 2005. Dr. Corcoran is a member of AOA and AUA.

Dr. Corcoran is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.